Compile Data Set for Download or QSAR
maximum 50k data
Found 58 with Last Name = 'shipman' and Initial = 'j'
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5284(4-{[4-(Methylsulfonyl)piperazin-1-yl]methyl}-N-(5-...)
Affinity DataIC50:  2nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5282((5-Phenylthiazol-2-yl)(4-pyrrolidin-1-ylmethylpyri...)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5281(5-phenyl-N-[5-(pyrrolidin-1-ylmethyl)pyridin-2-yl]...)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5292(2-({4-[(4-methanesulfonylpiperidin-1-yl)methyl]pyr...)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5280(5-phenyl-N-(pyridin-2-yl)-1,3-thiazol-2-amine | N-...)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5283(1-[4-({2-[(5-phenyl-1,3-thiazol-2-yl)amino]pyridin...)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5287(2-(4-Morpholin-4-ylmethylpyridin-2-ylamino)thiazol...)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5288(4-({2-[(5-Cyano-1,3-thiazol-2-yl)amino]-4-pyridiny...)
Affinity DataIC50:  8nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179415(2-(6-(4-(2-methoxyethyl)piperazin-1-yl)pyrimidin-4...)
Affinity DataIC50:  9nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5291(2-[(4-{[4-(2-hydroxyacetyl)piperazin-1-yl]methyl}p...)
Affinity DataIC50:  9nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179418(2-(6-(4-aminoazepan-1-yl)pyrimidin-4-ylamino)thiaz...)
Affinity DataIC50:  9nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179427(2-(6-(4-(2-(pyrrolidin-1-yl)ethyl)piperazin-1-yl)p...)
Affinity DataIC50:  9nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179417(2-(6-(4-methylpiperazin-1-yl)pyrimidin-4-ylamino)t...)
Affinity DataIC50:  10nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5289(4-({2-[(5-Cyano-1,3-thiazol-2-yl)amino]-4-pyridiny...)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179420(2-(6-(4-(3-morpholinopropyl)piperazin-1-yl)pyrimid...)
Affinity DataIC50:  10nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179413(2-(6-(4-aminopiperidin-1-yl)pyrimidin-4-ylamino)th...)
Affinity DataIC50:  10nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179427(2-(6-(4-(2-(pyrrolidin-1-yl)ethyl)piperazin-1-yl)p...)
Affinity DataIC50:  11nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5290(4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]pyridin-4-y...)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5293(4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]-3-methylpy...)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179414(2-(6-(4-(2-morpholinoethyl)piperazin-1-yl)pyrimidi...)
Affinity DataIC50:  12nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5285(2-({4-[(4-acetylpiperazin-1-yl)methyl]pyridin-2-yl...)
Affinity DataIC50:  13nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179416(2-(6-(4-acetylpiperazin-1-yl)pyrimidin-4-ylamino)t...)
Affinity DataIC50:  13nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5307(1-methanesulfonyl-4-[(4-{3-phenylimidazo[1,2-a]pyr...)
Affinity DataIC50:  13nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179418(2-(6-(4-aminoazepan-1-yl)pyrimidin-4-ylamino)thiaz...)
Affinity DataIC50:  15nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5286(2-(4-Piperazin-1-ylmethylpyridin-2-ylamino)thiazol...)
Affinity DataIC50:  15nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179421((rac)-2-(6-(3-aminopyrrolidin-1-yl)pyrimidin-4-yla...)
Affinity DataIC50:  16nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179422(2-(6-(piperazin-1-yl)pyrimidin-4-ylamino)thiazole-...)
Affinity DataIC50:  16nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179414(2-(6-(4-(2-morpholinoethyl)piperazin-1-yl)pyrimidi...)
Affinity DataIC50:  19nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179421((rac)-2-(6-(3-aminopyrrolidin-1-yl)pyrimidin-4-yla...)
Affinity DataIC50:  21nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179415(2-(6-(4-(2-methoxyethyl)piperazin-1-yl)pyrimidin-4...)
Affinity DataIC50:  22nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179417(2-(6-(4-methylpiperazin-1-yl)pyrimidin-4-ylamino)t...)
Affinity DataIC50:  23nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179420(2-(6-(4-(3-morpholinopropyl)piperazin-1-yl)pyrimid...)
Affinity DataIC50:  23nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179423(2-(6-(1,4-diazepan-1-yl)pyrimidin-4-ylamino)thiazo...)
Affinity DataIC50:  27nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5308(4-{3-phenylimidazo[1,2-a]pyridin-7-yl}-1-[3-(piper...)
Affinity DataIC50:  28nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179423(2-(6-(1,4-diazepan-1-yl)pyrimidin-4-ylamino)thiazo...)
Affinity DataIC50:  32nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179422(2-(6-(piperazin-1-yl)pyrimidin-4-ylamino)thiazole-...)
Affinity DataIC50:  34nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179425(2-(6-aminopyrimidin-4-ylamino)thiazole-5-carbonitr...)
Affinity DataIC50:  41nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5301(2-{7-phenylimidazo[1,2-a]pyridin-3-yl}-1,3-thiazol...)
Affinity DataIC50:  42nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179416(2-(6-(4-acetylpiperazin-1-yl)pyrimidin-4-ylamino)t...)
Affinity DataIC50:  44nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5303(4-{7-phenylimidazo[1,2-a]pyridin-3-yl}-1,2-thiazol...)
Affinity DataIC50:  50nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5305(N-methyl-4-[(4-{3-phenylimidazo[1,2-a]pyridin-7-yl...)
Affinity DataIC50:  52nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM50179413(2-(6-(4-aminopiperidin-1-yl)pyrimidin-4-ylamino)th...)
Affinity DataIC50:  59nMAssay Description:Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5311(1-(3-{3-[(dimethylamino)methyl]piperidin-1-yl}prop...)
Affinity DataIC50:  67nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5306(4-[(4-{3-phenylimidazo[1,2-a]pyridin-7-yl}phenyl)m...)
Affinity DataIC50:  69nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5294(3,6-diarylpyrazolo[1,5-a]pyrimidine 1 | 6-(4-metho...)
Affinity DataIC50:  71nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5304(1-{4-[(4-{3-phenylimidazo[1,2-a]pyridin-7-yl}pheny...)
Affinity DataIC50:  77nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5310(1-{3-[(2-methoxyethyl)(methyl)amino]propyl}-4-{3-p...)
Affinity DataIC50:  96nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5296(3,7-diphenylimidazo[1,2-a]pyridine | imidazopyridi...)
Affinity DataIC50:  98nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5302(5-{7-phenylimidazo[1,2-a]pyridin-3-yl}-1,3-thiazol...)
Affinity DataIC50:  99nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Merck Research Laboratories

LigandPNGBDBM5295(5-(4-methoxyphenyl)-1-phenyl-1H-1,3-benzodiazole |...)
Affinity DataIC50:  113nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 58 total ) | Next | Last >>
Jump to: